Table 1.
Subject Characteristics
| DHEA | Placebo | Between Group | ||
|---|---|---|---|---|
| (n = 46) | (n = 46) | P value | ||
| Sex | ||||
| Men | 20 (43%) | 22 (48%) | ||
| Women | 26 (57%) | 24 (52%) | 0.68 | |
| Race | ||||
| African American/Black | 1 (2%) | 2 (4%) | ||
| White | 45 (98%) | 44 (96%) | 0.56 | |
| Education | ||||
| < College degree | 24 (52%) | 19 (41%) | ||
| College degree | 12 (26%) | 13 (28%) | ||
| Graduate School | 10 (22%) | 14 (30%) | 0.52 | |
| Age, yr | 70 ± 3 | 70 ± 3 | 0.95 | |
| Weight, kg | ||||
| Men | 87.9 ± 14.6 | 83.4 ± 12.6 | 0.29 | |
| Women | 71.4 ± 16.6 | 76.1 ± 18.9 | 0.36 | |
| BMI, kg/m2 | 27.7 ± 5.5 | 27.8 ± 5.3 | 0.95 | |
| Medication use | ||||
| Anti-dyslipidemic | 16 (35%) | 24 (52%) | 0.09 | |
| Antihypertensive | 23 (50%) | 23 (50%) | 1.00 | |
| Multivitamin | 28 (61%) | 33 (72%) | 0.27 | |
| Vitamin C and/or E | 23 (50 %) | 18 (39 %) | 0.29 | |
| Self-reported diagnoses | ||||
| Cardiovascular disease | 5 (10%) | 6 (13%) | 0.75 | |
| Hypertension | 20 (43%) | 18 (39 %) | 0.67 | |
Values are means ± SD or n (% of participants). P-values are for independent t-tests for quantitative data and chi-square tests or fisher’s exact tests for counts. BMI, body mass index.